Title:
クローナル幹細胞を含む移植片対宿主病の治療用薬学的組成物
Document Type and Number:
Japanese Patent JP7389507
Kind Code:
B2
Abstract:
The present disclosure relates to a composition for preventing, treating, or alleviating graft-versus-host disease, containing monoclonal stem cells obtained by subfractionation culture of stem cells, and to a graft-versus-host disease treatment method using the same. According to a method of subfractionation culture and proliferation of stem cells of the present disclosure, it is possible to obtain a large quantity of desired monoclonal stem cells in a short time by rapid proliferation of monoclonal stem cells, and the monoclonal stem cells obtained thereby are stem cells with enhanced therapeutic effects on graft-versus-host disease, and thus can be beneficially used as a graft-versus-host disease therapeutic agent.
Inventors:
Son, Son Wook
Kim, Sina
Mun, Chung Hyeon
Kim, Sina
Mun, Chung Hyeon
Application Number:
JP2021534906A
Publication Date:
November 30, 2023
Filing Date:
December 04, 2019
Export Citation:
Assignee:
SCM Life Science Company Limited
International Classes:
A61K35/28; A61P37/06
Domestic Patent References:
| JP2010527988A | ||||
| JP2009183307A | ||||
| JP2009540865A | ||||
| JP2022513222A | ||||
| JP2006109757A |
Foreign References:
| WO2018074758A1 | ||||
| KR1020160002490A |
Attorney, Agent or Firm:
Yukitaka Nakamura
Manabu Miyajima
Mari Asano
Hiroshi Sorimachi
Manabu Miyajima
Mari Asano
Hiroshi Sorimachi